Loading…
Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and...
Saved in:
Published in: | FEBS letters 2024-04, Vol.598 (8), p.902-914 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 914 |
container_issue | 8 |
container_start_page | 902 |
container_title | FEBS letters |
container_volume | 598 |
creator | Ohgita, Takashi Sakai, Koto Fukui, Nodoka Namba, Norihiro Nakano, Miyu Kiguchi, Yuki Morita, Izumi Oyama, Hiroyuki Yamaki, Kouya Nagao, Kohjiro Kobayashi, Norihiro Saito, Hiroyuki |
description | Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms.
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform. |
doi_str_mv | 10.1002/1873-3468.14858 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153149425</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153149425</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613</originalsourceid><addsrcrecordid>eNqFkT1PwzAQhi0EoqUws6GMLCn-TOwRqrYgVWLpjOXEFzBK4hCnoDLxE_iN_BLSD7oy3d17z51O9yJ0SfCYYExviExZzHgix4RLIY_Q8KAcoyHGhMciVWyAzkJ4xX0tiTpFAyYFVSmmQ_Q0hxpa0zlfR76Iav8OZWTqzv18fZvGT6PK1z4vfW12cuatgxB1L6aLApSQd66fWEct5P65dp8Qbadc8IVvq3COTgpTBrjYxxFazqbLyX28eJw_TG4XcUMVkbHBljNjlZSQFUliSWYF7W9lglNphSC9AIrmNmNFkoMlVnKTEZC0yFVC2Ahd79Y2rX9bQeh05UIOZWlq8KugGRGMcMWp-B_FnKUSS6V69GqPrrIKrG5aV5l2rf--1wPJDvhwJawPfYL1xhy9sUJvrNBbc_Rseke3GfsF9geC6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043780899</pqid></control><display><type>article</type><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><source>Wiley</source><creator>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</creator><creatorcontrib>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</creatorcontrib><description>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms.
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.14858</identifier><identifier>PMID: 38529702</identifier><language>eng</language><publisher>England</publisher><subject>amyloid ; apoE isoform ; apolipoprotein E ; brain ; cholesterol ; dissociation ; enzyme-linked immunosorbent assay ; epitopes ; humans ; interferometry ; lipid metabolism ; monoclonal antibody ; sandwich ELISA</subject><ispartof>FEBS letters, 2024-04, Vol.598 (8), p.902-914</ispartof><rights>2024 Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0009-0002-2631-318X ; 0000-0003-1497-1425</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38529702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohgita, Takashi</creatorcontrib><creatorcontrib>Sakai, Koto</creatorcontrib><creatorcontrib>Fukui, Nodoka</creatorcontrib><creatorcontrib>Namba, Norihiro</creatorcontrib><creatorcontrib>Nakano, Miyu</creatorcontrib><creatorcontrib>Kiguchi, Yuki</creatorcontrib><creatorcontrib>Morita, Izumi</creatorcontrib><creatorcontrib>Oyama, Hiroyuki</creatorcontrib><creatorcontrib>Yamaki, Kouya</creatorcontrib><creatorcontrib>Nagao, Kohjiro</creatorcontrib><creatorcontrib>Kobayashi, Norihiro</creatorcontrib><creatorcontrib>Saito, Hiroyuki</creatorcontrib><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms.
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</description><subject>amyloid</subject><subject>apoE isoform</subject><subject>apolipoprotein E</subject><subject>brain</subject><subject>cholesterol</subject><subject>dissociation</subject><subject>enzyme-linked immunosorbent assay</subject><subject>epitopes</subject><subject>humans</subject><subject>interferometry</subject><subject>lipid metabolism</subject><subject>monoclonal antibody</subject><subject>sandwich ELISA</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkT1PwzAQhi0EoqUws6GMLCn-TOwRqrYgVWLpjOXEFzBK4hCnoDLxE_iN_BLSD7oy3d17z51O9yJ0SfCYYExviExZzHgix4RLIY_Q8KAcoyHGhMciVWyAzkJ4xX0tiTpFAyYFVSmmQ_Q0hxpa0zlfR76Iav8OZWTqzv18fZvGT6PK1z4vfW12cuatgxB1L6aLApSQd66fWEct5P65dp8Qbadc8IVvq3COTgpTBrjYxxFazqbLyX28eJw_TG4XcUMVkbHBljNjlZSQFUliSWYF7W9lglNphSC9AIrmNmNFkoMlVnKTEZC0yFVC2Ahd79Y2rX9bQeh05UIOZWlq8KugGRGMcMWp-B_FnKUSS6V69GqPrrIKrG5aV5l2rf--1wPJDvhwJawPfYL1xhy9sUJvrNBbc_Rseke3GfsF9geC6Q</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Ohgita, Takashi</creator><creator>Sakai, Koto</creator><creator>Fukui, Nodoka</creator><creator>Namba, Norihiro</creator><creator>Nakano, Miyu</creator><creator>Kiguchi, Yuki</creator><creator>Morita, Izumi</creator><creator>Oyama, Hiroyuki</creator><creator>Yamaki, Kouya</creator><creator>Nagao, Kohjiro</creator><creator>Kobayashi, Norihiro</creator><creator>Saito, Hiroyuki</creator><scope>NPM</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0009-0002-2631-318X</orcidid><orcidid>https://orcid.org/0000-0003-1497-1425</orcidid></search><sort><creationdate>202404</creationdate><title>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</title><author>Ohgita, Takashi ; Sakai, Koto ; Fukui, Nodoka ; Namba, Norihiro ; Nakano, Miyu ; Kiguchi, Yuki ; Morita, Izumi ; Oyama, Hiroyuki ; Yamaki, Kouya ; Nagao, Kohjiro ; Kobayashi, Norihiro ; Saito, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>amyloid</topic><topic>apoE isoform</topic><topic>apolipoprotein E</topic><topic>brain</topic><topic>cholesterol</topic><topic>dissociation</topic><topic>enzyme-linked immunosorbent assay</topic><topic>epitopes</topic><topic>humans</topic><topic>interferometry</topic><topic>lipid metabolism</topic><topic>monoclonal antibody</topic><topic>sandwich ELISA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohgita, Takashi</creatorcontrib><creatorcontrib>Sakai, Koto</creatorcontrib><creatorcontrib>Fukui, Nodoka</creatorcontrib><creatorcontrib>Namba, Norihiro</creatorcontrib><creatorcontrib>Nakano, Miyu</creatorcontrib><creatorcontrib>Kiguchi, Yuki</creatorcontrib><creatorcontrib>Morita, Izumi</creatorcontrib><creatorcontrib>Oyama, Hiroyuki</creatorcontrib><creatorcontrib>Yamaki, Kouya</creatorcontrib><creatorcontrib>Nagao, Kohjiro</creatorcontrib><creatorcontrib>Kobayashi, Norihiro</creatorcontrib><creatorcontrib>Saito, Hiroyuki</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohgita, Takashi</au><au>Sakai, Koto</au><au>Fukui, Nodoka</au><au>Namba, Norihiro</au><au>Nakano, Miyu</au><au>Kiguchi, Yuki</au><au>Morita, Izumi</au><au>Oyama, Hiroyuki</au><au>Yamaki, Kouya</au><au>Nagao, Kohjiro</au><au>Kobayashi, Norihiro</au><au>Saito, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2024-04</date><risdate>2024</risdate><volume>598</volume><issue>8</issue><spage>902</spage><epage>914</epage><pages>902-914</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and apoE4 only differ in one or two residues. Nevertheless, the functions highly depend on the isoform types and lipidated states. Here, we generated novel anti‐apoE monoclonal antibodies (mAbs) and obtained an apoE4‐selective mAb whose epitope is within residues 110–117. ELISA and bio‐layer interferometry measurements demonstrated that the dissociation constants of mAbs are within the nanomolar range. Using the generated antibodies, we successfully constructed sandwich ELISA systems, which can detect all apoE isoforms or selectively detect apoE4. These results suggest the usability of the generated anti‐apoE mAbs for selective detection of apoE isoforms.
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. Human apoE4 isoform is a risk factor for apoE‐related diseases, although only one or two residues are different in other isoforms. Here, we generated novel anti‐apoE monoclonal antibodies and constructed a sandwich ELISA system to selectively detect the apoE4 isoform.</abstract><cop>England</cop><pmid>38529702</pmid><doi>10.1002/1873-3468.14858</doi><tpages>13</tpages><orcidid>https://orcid.org/0009-0002-2631-318X</orcidid><orcidid>https://orcid.org/0000-0003-1497-1425</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-5793 |
ispartof | FEBS letters, 2024-04, Vol.598 (8), p.902-914 |
issn | 0014-5793 1873-3468 |
language | eng |
recordid | cdi_proquest_miscellaneous_3153149425 |
source | Wiley |
subjects | amyloid apoE isoform apolipoprotein E brain cholesterol dissociation enzyme-linked immunosorbent assay epitopes humans interferometry lipid metabolism monoclonal antibody sandwich ELISA |
title | Generation of novel anti‐apoE monoclonal antibodies that selectively recognize apoE isoforms |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A42%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Generation%20of%20novel%20anti%E2%80%90apoE%20monoclonal%20antibodies%20that%20selectively%20recognize%20apoE%20isoforms&rft.jtitle=FEBS%20letters&rft.au=Ohgita,%20Takashi&rft.date=2024-04&rft.volume=598&rft.issue=8&rft.spage=902&rft.epage=914&rft.pages=902-914&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.14858&rft_dat=%3Cproquest_pubme%3E3153149425%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p2918-a0d43ad988ebf66d1bd5218135428d5511bde92cdb3f6ced1d84ab1e82fc9613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3043780899&rft_id=info:pmid/38529702&rfr_iscdi=true |